Coronavirus
-
News
Libya’s GNA allocates 600 million dinars for Covid-19 response
The Libyan Government of National Accord (GNA) has allocated 600 million dinars as an emergency fund to provide Covid-19 vaccines…
Read More » -
News
Libya to buy Covid-19 vaccine for over $9.6 million
The Libyan Audit Bureau in Tripoli has given the green light for buying a newly developed vaccine for Coronavirus in…
Read More » -
News
Pfizer and BioNTech announce 90% effective Covid19 vaccine
A Covid-19 vaccine being developed by Pfizer and Germany’s BioNTech has been found to be more than 90 per cent…
Read More » -
News
Libya’s Covid-19 cases near 40.000
The National Center for Disease Control of Libya on Monday reported 1,031 COVID-19 cases in the previous 24 hours, bringing…
Read More » -
News
Libya’s Covid-19 cases jump to over 36.000
Libya reported Saturday 370 new COVID-19 cases, bringing the total confirmed caseload in the country to 36.087, according to the…
Read More » -
News
Libya announces four-day total lockdown amid rising Covid-19 cases
Libya’s Presidential Council of the Government of National Accord (GNA) on Wednesday announced a four-day total curfew in the capital…
Read More » -
News
Libya records 553 new Covid-19 cases, bringing total to 11.834
The Libyan National Center for Disease Control announced registering 553 new coronavirus cases in Libya on Tuesday in what would…
Read More » -
News
US firm, Moderna, kick-starts Phase III clinical trial of COVID-19 vaccine candidate
Moderna has announced that the Phase III study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants. The Phase III study,…
Read More » -
News
Libya’s COVID-19 cases exceed 1000 threshold
The National Center for Disease Control of Libya reported Monday 57 new COVID-19 cases, bringing the total confirmed cases in…
Read More » -
News
Libya’s Coronavirus cases reach 918 as 230 patients recover
The Libyan National Center for Disease Control has registered 27 new COVID-19 cases and six recoveries as well as one…
Read More »